Our results show that the levels of CD109, IL6Rα, pSTAT3 and NRF2 are markedly upregulated in tumor sections compared to normal tissue and CD109 levels correlate significantly with those of IL6Rα/pSTAT3/NRF2 (Fig. 8A, Figure S8). This evidence concerns the gene CD109 and neoplasm.